Previous 10 | Next 10 |
2023-07-10 09:33:48 ET Things are starting to defrost for the IPO market after being frozen for much of the past year and a half. In June, investors witnessed the notable IPOs of Vesta Real Estate ( VTMX ), Kodiak Gas Services ( KGS ), Savers Value Village ( SVV ) and Fideli...
Leader in Hormone Education and Training Aims to Increase Awareness and Access to Testosterone Deficiency Therapy through Expanded Network of Urologists and Internal Medicine Practitioners biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading provi...
Biote (NASDAQ: BTMD) , a leading provider of preventive health care through the delivery of personalized hormone therapy, has closed an underwritten public offering of 5,793,500 shares of its Class A common stock by one of its stockholders. According to the update, the shares were sold at a publi...
Biote (NASDAQ: BTMD) (the “Company,” “we” or “us”), a leading solutions provider in preventive healthcare through the delivery of personalized hormone therapy, today announced the expiration and results of its previously announced (i) offer to each holder...
2023-06-05 08:49:46 ET Personalised hormone therapy provider, biote ( NASDAQ: BTMD ) prices an underwritten offering of 5,217,392 shares at a price of $5.35 per share. Underwriters have a 30-day option to purchase an aggregate of not more than 782,608 additional shar...
biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced its participation at the following investor conferences: On June 6, 2023, Terry W...
2023-05-30 09:04:15 ET Preventive health care solutions company biote ( NASDAQ: BTMD ) said on Tuesday that Mary Puncochar has been appointed chief commercial officer. Puncochar has previously served as head of the U.S. region at Ascensia Diabetes Care. ...
Ms. Puncochar to Drive Execution of Biote’s Strategic Sales and Marketing Initiatives biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy...
2023-05-10 10:00:34 ET Gainers: CTI BioPharma ( CTIC ) +85% . Cano Health ( CANO ) +29% . TScan Therapeutics ( TCRX ) +24% . RxSight ( RXST ) +11% . Guardant Health ( GH ) +14% . Losers: Babylon Holdings ( BBLN ) -71...
2023-05-09 19:09:06 ET Biote press release ( NASDAQ: BTMD ): Q1 GAAP EPS of -$0.39. Revenue of $44.8M (+20.8% Y/Y). Maintains FY 2023 revenue guidance of $190M-$200M vs. consensus of $193.87M. For further details see: Biote reports Q1 results, maintains F...
News, Short Squeeze, Breakout and More Instantly...
2024-07-06 18:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-26 20:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has signed a binding term sheet with Marci M. Donovitz...